Sign up to save your podcasts
Or
Share Seth Berkley on vaccines, COVID, and equity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Seth Berkley on vaccines, COVID, and equity
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses.
Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic.
We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for strengthening international cooperation and ensuring that future advances in vaccine science benefit everyone, everywhere.
Send us your feedback!
Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancet
Check out all the podcasts from The Lancet Group:
https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancet
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
2121 ratings
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses.
Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic.
We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for strengthening international cooperation and ensuring that future advances in vaccine science benefit everyone, everywhere.
Send us your feedback!
Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancet
Check out all the podcasts from The Lancet Group:
https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancet
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Voice
View all
TED Talks Daily
11,099 Listeners
Global News Podcast
7,913 Listeners
NEJM This Week
321 Listeners
This Week in Virology
2,053 Listeners
JAMA Clinical Reviews
504 Listeners
Nature Podcast
756 Listeners
BBC Inside Science
410 Listeners
Science Weekly
429 Listeners
Science Magazine Podcast
818 Listeners
TED Health
1,406 Listeners
The Audio Long Read
841 Listeners
Unexpected Elements
363 Listeners
The Intelligence from The Economist
2,592 Listeners
Life Kit
4,807 Listeners
Public Health On Call
631 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
3 Listeners
The Lancet Oncology in conversation with
1 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet Respiratory Medicine in conversation with
1 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
1 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
eBioMedicine in conversation with
0 Listeners
In conversation with...
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Lancet Regional Health in conversation with
0 Listeners
The Lancet Primary Care in conversation with
0 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners